Takahashi Yoshiharu, Nishizawa Taketo, Suzuki Ryutaro, Murakami Kazuhiro, Kawagishi Jun, Jokura Hidefumi, Sasaki Tatsuya, Endo Toshiki
Division of Neurosurgery, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan.
Jiro Suzuki Memorial Gamma House, Furukawa Seiryo Hospital, Osaki, Miyagi, Japan.
J Neurosurg Case Lessons. 2025 Jul 14;10(2). doi: 10.3171/CASE2537.
Gamma Knife radiosurgery (GKRS) is an established therapeutic modality for vestibular schwannomas. However, various late-onset complications, including mass lesions resembling cavernous malformations, have been reported. Retiform endothelial hyperplasia (RFEH), a distinct vascular pathology, has recently been identified as a potential late-onset complication of GKRS for arteriovenous malformations. This report describes the first case of RFEH developing within a vestibular schwannoma 30 years after GKRS, necessitating surgical enucleation.
A 54-year-old man was diagnosed with a right-sided vestibular schwannoma at age 23 years and underwent GKRS with a dose of 13.6 Gy (40% isodose). The tumor exhibited long-term regression; however, at the 28-year follow-up, MRI revealed a progressively enlarging low-intensity T2-weighted ring within the tumor. At 30 years post-GKRS, resection was performed, revealing a well-circumscribed, encapsulated, hematoma-like lesion within the yellowish schwannoma. Histopathological analysis showed an old hematoma with irregular endothelium-lined cavities lacking fibrous or smooth muscle layers, confirming the diagnosis of RFEH. The surrounding tumor cells were S-100 protein-positive with a Ki-67 labeling index of 3%.
RFEH can develop within a vestibular schwannoma decades after GKRS, extending its known association beyond arteriovenous malformations. Recognizing this unique complication is critical for optimal patient management and surgical decision-making. https://thejns.org/doi/10.3171/CASE2537.
伽玛刀放射外科手术(GKRS)是一种成熟的前庭神经鞘瘤治疗方式。然而,已报道了各种迟发性并发症,包括类似海绵状畸形的肿块病变。网状内皮细胞增生(RFEH)是一种独特的血管病变,最近被确定为GKRS治疗动静脉畸形的潜在迟发性并发症。本报告描述了首例在GKRS 30年后在前庭神经鞘瘤内发生RFEH并需要手术摘除的病例。
一名54岁男性在23岁时被诊断为右侧前庭神经鞘瘤,并接受了剂量为13.6 Gy(40%等剂量线)的GKRS治疗。肿瘤呈长期消退;然而,在28年的随访中,MRI显示肿瘤内一个逐渐增大的低强度T2加权环。在GKRS治疗30年后进行了切除,发现在淡黄色的神经鞘瘤内有一个边界清楚、有包膜、血肿样病变。组织病理学分析显示为一个陈旧性血肿,有不规则的内皮细胞衬里腔隙,缺乏纤维或平滑肌层,证实了RFEH的诊断。周围的肿瘤细胞S-100蛋白阳性,Ki-67标记指数为3%。
RFEH可在GKRS治疗数十年后在前庭神经鞘瘤内发生,将其已知的关联范围扩展到动静脉畸形之外。认识到这种独特的并发症对于优化患者管理和手术决策至关重要。https://thejns.org/doi/10.3171/CASE2537 。